For chronic weight management, adults may generally qualify for Tirzepatide if they have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
There is no single universal calorie target for everyone taking semaglutide, as individual needs vary based on multiple factors including age, sex, height, current weight, activity level, and overall health status
After 6 months, IDegLira reduced HbA1c by 21 mmol/mol compared with reductions of 15 mmol/mol with Tresiba and 14 mmol/mol with Victoza
Most patients can continue GLP-1 medication before surgery, but some patients need extra precautions or may need to delay surgery if they have higher risk factors